Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.

Conditions:   Cirrhosis, Liver;   Ascites Hepatic Interventions:   Drug: Ularitide;   Drug: Placebo Sponsors:   University of Aarhus;   Aarhus University Hospital;   ADS AIPHIA Development Services AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials